BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26032282)

  • 1. Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.
    Juhlin CC; Stenman A; Haglund F; Clark VE; Brown TC; Baranoski J; Bilguvar K; Goh G; Welander J; Svahn F; Rubinstein JC; Caramuta S; Yasuno K; Günel M; Bäckdahl M; Gimm O; Söderkvist P; Prasad ML; Korah R; Lifton RP; Carling T
    Genes Chromosomes Cancer; 2015 Sep; 54(9):542-54. PubMed ID: 26032282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma.
    Stenman A; Svahn F; Welander J; Gustavson B; Söderkvist P; Gimm O; Juhlin CC
    Endocr Pathol; 2015 Mar; 26(1):9-14. PubMed ID: 25403449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATRX driver mutation in a composite malignant pheochromocytoma.
    Comino-Méndez I; Tejera ÁM; Currás-Freixes M; Remacha L; Gonzalvo P; Tonda R; Letón R; Blasco MA; Robledo M; Cascón A
    Cancer Genet; 2016 Jun; 209(6):272-7. PubMed ID: 27209355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
    Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genomic landscape of phaeochromocytoma.
    Flynn A; Benn D; Clifton-Bligh R; Robinson B; Trainer AH; James P; Hogg A; Waldeck K; George J; Li J; Fox SB; Gill AJ; McArthur G; Hicks RJ; Tothill RW
    J Pathol; 2015 May; 236(1):78-89. PubMed ID: 25545346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.
    Fishbein L; Khare S; Wubbenhorst B; DeSloover D; D'Andrea K; Merrill S; Cho NW; Greenberg RA; Else T; Montone K; LiVolsi V; Fraker D; Daber R; Cohen DL; Nathanson KL
    Nat Commun; 2015 Jan; 6():6140. PubMed ID: 25608029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma.
    Welander J; Andreasson A; Brauckhoff M; Bäckdahl M; Larsson C; Gimm O; Söderkvist P
    Endocr Relat Cancer; 2014 Jun; 21(3):495-504. PubMed ID: 24741025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating FGFR1 Mutations in Sporadic Pheochromocytomas.
    Welander J; Łysiak M; Brauckhoff M; Brunaud L; Söderkvist P; Gimm O
    World J Surg; 2018 Feb; 42(2):482-489. PubMed ID: 29159601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance).
    Augert A; Zhang Q; Bates B; Cui M; Wang X; Wildey G; Dowlati A; MacPherson D
    J Thorac Oncol; 2017 Apr; 12(4):704-713. PubMed ID: 28007623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.
    Oudijk L; de Krijger RR; Rapa I; Beuschlein F; de Cubas AA; Dei Tos AP; Dinjens WN; Korpershoek E; Mancikova V; Mannelli M; Papotti M; Vatrano S; Robledo M; Volante M
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1376-80. PubMed ID: 24684458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
    Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
    Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.
    Castro-Vega LJ; Letouzé E; Burnichon N; Buffet A; Disderot PH; Khalifa E; Loriot C; Elarouci N; Morin A; Menara M; Lepoutre-Lussey C; Badoual C; Sibony M; Dousset B; Libé R; Zinzindohoue F; Plouin PF; Bertherat J; Amar L; de Reyniès A; Favier J; Gimenez-Roqueplo AP
    Nat Commun; 2015 Jan; 6():6044. PubMed ID: 25625332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
    Stenman A; Zedenius J; Juhlin CC
    Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes.
    Wilzén A; Rehammar A; Muth A; Nilsson O; Tešan Tomić T; Wängberg B; Kristiansson E; Abel F
    Int J Cancer; 2016 May; 138(9):2201-11. PubMed ID: 26650627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.
    Comino-Méndez I; de Cubas AA; Bernal C; Álvarez-Escolá C; Sánchez-Malo C; Ramírez-Tortosa CL; Pedrinaci S; Rapizzi E; Ercolino T; Bernini G; Bacca A; Letón R; Pita G; Alonso MR; Leandro-García LJ; Gómez-Graña A; Inglada-Pérez L; Mancikova V; Rodríguez-Antona C; Mannelli M; Robledo M; Cascón A
    Hum Mol Genet; 2013 Jun; 22(11):2169-76. PubMed ID: 23418310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas.
    McInerney-Leo AM; Marshall MS; Gardiner B; Benn DE; McFarlane J; Robinson BG; Brown MA; Leo PJ; Clifton-Bligh RJ; Duncan EL
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):25-33. PubMed ID: 24102379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the inheritance pattern of a Chinese family with phaeochromocytomas through whole exome sequencing.
    Cao M; Sun F; Huang X; Dai J; Cui B; Ning G
    Gene; 2013 Sep; 526(2):164-9. PubMed ID: 23707928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.
    Fishbein L; Leshchiner I; Walter V; Danilova L; Robertson AG; Johnson AR; Lichtenberg TM; Murray BA; Ghayee HK; Else T; Ling S; Jefferys SR; de Cubas AA; Wenz B; Korpershoek E; Amelio AL; Makowski L; Rathmell WK; Gimenez-Roqueplo AP; Giordano TJ; Asa SL; Tischler AS; ; Pacak K; Nathanson KL; Wilkerson MD
    Cancer Cell; 2017 Feb; 31(2):181-193. PubMed ID: 28162975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary.
    Hillman RT; Celestino J; Terranova C; Beird HC; Gumbs C; Little L; Nguyen T; Thornton R; Tippen S; Zhang J; Lu KH; Gershenson DM; Rai K; Broaddus RR; Futreal PA
    Nat Commun; 2018 Jun; 9(1):2496. PubMed ID: 29950560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
    Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
    Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.